\
&
Contact us
\
&
Contact us
This was 10 months ago
Locationonline
ProgrammesThe CETPartnership launches it's third Joint Call on 19 September 2024!
One week before, they invite you to a comprehensive information event on the Joint Call 2024. Would you like to apply for funding in the Joint Call 2024? Find all relevant information about during our Call Launch Event: call stages, structure and topics (call modules), transnational and national eligibility rules, and Q&A.
If you are a technology provider, research institution, infrastructure provider, industrial or energy company (experienced or new) interested in receiving funding for your ideas or in need of innovative clean energy solutions, then this event is for you. We also welcome interested stakeholders from EU platforms, media, and the public that want to find out more about CETPartnership.
More information and registration : here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
